Rudman Errol M Lowers stake in DENTSPLY International (XRAY)

DENTSPLY International (XRAY) : Rudman Errol M reduced its stake in DENTSPLY International by 53.73% during the most recent quarter end. The investment management company now holds a total of 58,248 shares of DENTSPLY International which is valued at $3,554,293 after selling 67,642 shares in DENTSPLY International , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.DENTSPLY International makes up approximately 3.27% of Rudman Errol M’s portfolio.

Other Hedge Funds, Including , Envestnet Asset Management Inc reduced its stake in XRAY by selling 2,448 shares or 3.29% in the most recent quarter. The Hedge Fund company now holds 71,913 shares of XRAY which is valued at $4,388,131. DENTSPLY International makes up approx 0.02% of Envestnet Asset Management Inc’s portfolio.De Burlo Group Inc reduced its stake in XRAY by selling 60,550 shares or 31.44% in the most recent quarter. The Hedge Fund company now holds 132,050 shares of XRAY which is valued at $8,185,780. DENTSPLY International makes up approx 1.93% of De Burlo Group Inc’s portfolio.Candriam Luxembourg S.c.a. boosted its stake in XRAY in the latest quarter, The investment management firm added 73,230 additional shares and now holds a total of 212,680 shares of DENTSPLY International which is valued at $13,311,641. DENTSPLY International makes up approx 0.34% of Candriam Luxembourg S.c.a.’s portfolio.Parkwood reduced its stake in XRAY by selling 1,399 shares or 14.74% in the most recent quarter. The Hedge Fund company now holds 8,091 shares of XRAY which is valued at $507,548. DENTSPLY International makes up approx 0.08% of Parkwood’s portfolio. Gavekal Capital sold out all of its stake in XRAY during the most recent quarter. The investment firm sold 261,290 shares of XRAY which is valued $16,390,722.

DENTSPLY International opened for trading at $61.64 and hit $61.9 on the upside on Thursday, eventually ending the session at $61.65, with a gain of 0.31% or 0.19 points. The heightened volatility saw the trading volume jump to 9,94,841 shares. Company has a market cap of $14,365 M.

On the company’s financial health, DENTSPLY International reported $0.76 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Aug 5, 2016. Analyst had a consensus of $0.70. The company had revenue of $1022.00 million for the quarter, compared to analysts expectations of $1028.82 million. The company’s revenue was up 46.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 EPS.

Many Wall Street Analysts have commented on DENTSPLY International. DENTSPLY International was Downgraded by Barrington Research to ” Mkt Perform” on Aug 8, 2016. DENTSPLY International was Initiated by Piper Jaffray to “Overweight” on Jun 13, 2016.

DENTSPLY International Inc. is a designer developer manufacturer and marketer of a range of consumable dental products for the professional dental market. It operates through three segments: Dental Consumable and Certain International Businesses; Dental Specialty and Laboratory and Certain Global Distribution Businesses and Healthcare and Emerging Markets Businesses. All the segments are primarily engaged in the design manufacture and distribution of dental and medical products in four product categories. Its Dental Consumable Products consist of dental supplies and devices and small equipment used in dental offices. Its Dental Laboratory Products are used in the preparation of dental appliances by dental laboratories. Its Dental Specialty Products are specialized treatment products used within the dental office and laboratory settings. Its Consumable Medical Device Products consist mainly of urology catheters certain surgical products medical drills and other products.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *